Ignite Creation Date:
2025-12-24 @ 9:46 PM
Ignite Modification Date:
2025-12-26 @ 2:13 PM
Study NCT ID:
NCT04961632
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-01
First Post:
2021-07-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376
Sponsor:
National Cancer Centre, Singapore
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-23
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-11
Completion Date Type:
ESTIMATED
First Submit Date:
2021-07-05
First Submit QC Date:
None
Study First Post Date:
2021-07-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-30
Last Update Post Date:
2024-02-01
Last Update Post Date Type:
ACTUAL